CoChat

Alcohol consumption, mild cognitive impairment, and progression to dementia

Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Baldassarre, G., Scapicchio, P., Scafato, E., Amodio, M., Capurso, A., Panza, F. · 2007 · Neurology
Cited by 154

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Near-infrared dye-tagged antibodies can be used for the sensitive detection of tumor tissue in vivo. Surgery for clear-cell renal cell carcinoma (ccRCC) might benefit from the use of optical imaging to facilitate the intraoperative detection of carbonic anhydrase IX (CAIX)–expressing tumor lesions with chimeric monoclonal antibody (mAb) girentuximab, which has been shown to have excellent imaging capabilities for ccRCC. Here we studied the potential of fluorescence imaging to detect ccRCC tumors in nude mice with RCC xenografts by using mAb girentuximab conjugated with IRDye800CW; SPECT imaging was used as a reference. Methods: Groups of athymic BALB/c mice with subcutaneous CAIX-positive SK-RC-52 ccRCC tumors were injected intravenously with 125I-labeled girentuximab-IRDye800CW or 125I-labeled girentuximab. For determination of the specificity of the accumulation of the anti-CAIX antibody conjugate in ccRCC, separate groups of mice bearing a CAIX-positive tumor (SK-RC-52) and a CAIX-negative tumor (SK-RC-59) received 125I-girentuximab-IRDye800CW or 125I-labeled MOPC21-IRDye800CW (control mAb). Optical images and micro-SPECT images were acquired until 3 d after injection. Mice were euthanized after the last imaging session, and the biodistribution of the radiolabeled antibody preparations was determined. Results: Optical imaging and micro-SPECT imaging at 1 d after the injection of 125I-girentuximab-IRDye800CW showed clear delineation of the CAIX-expressing ccRCC xenografts, and image contrast improved with time. Fluorescence imaging and biodistribution studies showed high and specific uptake of 125I-girentuximab-IRDye800CW in CAIX-positive ccRCC xenografts (SK-RC-52, 31.5 ± 9.6 percentage injected dose per gram [%ID/g] at 72 h after injection). Tumor uptake was specific, as very low uptake of 125I-girentuximab-IRDye800CW was noted in the CAIX-negative SK-RC-59 tumor (4.1 ± 1.5 %ID/g), and no uptake of 125I-MOPC21-IRDye800CW (control mAb) was noted in the CAIX-positive SK-RC-52 tumor (1.2 ± 0.1 %ID/g). Conclusion: Subcutaneous CAIX-expressing ccRCC xenografts were visualized by optical imaging with 125I-girentuximab-IRDye800CW. Optical images showed good concordance with micro-SPECT images. The accumulation of 125I-girentuximab-IRDye800CW in ccRCC tumors was high and specific. Girentuximab-IRDye800CW potentially could be used for the intraoperative detection of CAIX-expressing tumors and the assessment of residual tumor in resection margins or metastatic lesions in patients with ccRCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000262035.87304.89

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 36

  1. 10.1097/00019442-200508000-00002 · DOI
  2. 10.1212/01.WNL.0000144281.38555.E3 · DOI · Paper page
  3. 10.1016/j.neurobiolaging.2005.05.008 · DOI
  4. 10.1007/s00702-002-0766-8 · DOI · Paper page
  5. 10.1016/j.exger.2006.03.017 · DOI
  6. Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and the elderly: a prospective community study in the Bordeaux area. Rev Neur 1997;153:185–192.
  7. 10.1016/S0895-4356(02)00462-6 · DOI
  8. 10.1016/S0140-6736(02)07493-7 · DOI · Paper page
  9. 10.1212/01.WNL.0000031421.50369.E7 · DOI · Paper page
  10. 10.1001/jama.289.11.1405 · DOI · Paper page
  11. 10.1111/j.1532-5415.2004.52159.x · DOI · Paper page
  12. 10.1136/bmj.38181.418958.BE · DOI · Paper page
  13. 10.1093/aje/kwi043 · DOI · Paper page
  14. 10.1016/S0002-9149(02)02192-6 · DOI
  15. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  16. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987;6 (suppl 8):12–120.
  17. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv 1976;6:493–507.
  18. 10.1093/geronj/37.3.323 · DOI · Paper page
  19. 10.1136/jnnp.23.1.56 · DOI · Paper page
  20. 10.1212/WNL.34.7.939 · DOI · Paper page
  21. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Chapter V categories F00-F99. Mental behavioural and developmental disorders clinical description and diagnostic guidelines. Geneva: World Health Organization 1992.
  22. 10.1161/01.STR.24.12.1828 · DOI
  23. 10.1093/ajcn/80.4.992 · DOI
  24. 10.1016/S0301-0082(98)00032-X · DOI · Paper page
  25. 10.1182/blood.V64.3.679.679 · DOI
  26. 10.1111/j.1530-0277.1994.tb00888.x · DOI · Paper page
  27. 10.1001/jama.1994.03520120039028 · DOI · Paper page
  28. Meade TW, Chakrabarti R, Haines AP, et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. BMJ 1979;1:153–156.
  29. 10.1056/NEJM199312163292501 · DOI · Paper page
  30. 10.1001/jama.1985.03350430066027 · doi:10.1001/jama.1985.03350430066027
  31. 10.1161/01.CIR.85.3.910 · DOI · Paper page
  32. 10.1016/S0306-9877(02)00144-5 · DOI
  33. 10.1111/j.1749-6632.2002.tb02929.x · DOI
  34. 10.1093/jn/128.6.1003 · DOI · Paper page
  35. 10.1021/jf970489o · DOI · Paper page
  36. 10.1046/j.1365-2389.2003.51313.x · DOI

Cited by

See all 154

Metadata

Authors
Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Baldassarre, G., Scapicchio, P., Scafato, E., Amodio, M., Capurso, A., & Panza, F.
Venue
Neurology
Published
2007-05-22
Volume
68
Issue
21
Pages
1790-1799
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2026030309
Cited by
154
References
7
FWCI
8.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alcohol consumption, mild cognitive impairment, and progression to dementia. https://app.cochat.ai/papers/10.1212/01.wnl.0000262035.87304.89
The paper
Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Baldassarre, G., Scapicchio, P., Scafato, E., Amodio, M., Capurso, A., & Panza, F. (2007). Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology. https://doi.org/10.1212/01.wnl.0000262035.87304.89

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.